| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |